Clinical Trials Browser

Phase 1 × pexidartinib × Sarcoma × Clear all

NCT03158103 2021-04-30

A Study of MEK162 (Binimetinib) in Combination With Pexidartinib in Patients With Advanced Gastrointestinal Stromal Tumor (GIST)

Phase 1 Completed

GastrointestinalSarcoma

Gastrointestinal Stromal Tumors